Skip to main content
Journal cover image

Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.

Publication ,  Journal Article
De Luca, G; Suryapranata, H; Stone, GW; Antoniucci, D; Tcheng, JE; Neumann, F-J; Bonizzoni, E; Topol, EJ; Chiariello, M
Published in: J Am Coll Cardiol
February 7, 2006

Duke Scholars

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

February 7, 2006

Volume

47

Issue

3

Start / End Page

685 / 686

Location

United States

Related Subject Headings

  • Survival Rate
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Immunoglobulin Fab Fragments
  • Humans
  • Electrocardiography
  • Combined Modality Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
De Luca, G., Suryapranata, H., Stone, G. W., Antoniucci, D., Tcheng, J. E., Neumann, F.-J., … Chiariello, M. (2006). Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. J Am Coll Cardiol, 47(3), 685–686. https://doi.org/10.1016/j.jacc.2005.11.018
De Luca, Giuseppe, Harry Suryapranata, Gregg W. Stone, David Antoniucci, James E. Tcheng, Franz-Josef Neumann, Erminio Bonizzoni, Eric J. Topol, and Massimo Chiariello. “Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.J Am Coll Cardiol 47, no. 3 (February 7, 2006): 685–86. https://doi.org/10.1016/j.jacc.2005.11.018.
De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann F-J, Bonizzoni E, Topol EJ, Chiariello M. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. J Am Coll Cardiol. 2006 Feb 7;47(3):685–686.
Journal cover image

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

February 7, 2006

Volume

47

Issue

3

Start / End Page

685 / 686

Location

United States

Related Subject Headings

  • Survival Rate
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Immunoglobulin Fab Fragments
  • Humans
  • Electrocardiography
  • Combined Modality Therapy